Monocytes play an important role in hemostasis. In this study, the prothrombotic effects of the neuropeptide substance P (SP) on human monocytes through neurokinin-1 receptor (NK1-R) were characterized. SP upregulated monocyte tissue factor (TF), the major coagulation cascade stimulator, in a concentration and time dependent manner. Specific inhibition of NK1-R completely blocked TF expression. Monocytes stimulated by SP released cytokines and chemokines. When monocytes were stimulated with cytokines or chemokines, TF was expressed by the cytokines (GM-CSF, IFN-γ and TNF-α). Cytokines may play a major role in the mechanism of SP induced monocyte TF expression. NK1-R antagonists (NK1-RA) may have a role in developing novel therapeutic approaches to patients vulnerable to vaso-occlusive disorders.
Introduction
Plasma levels of the neuropeptide SP (Michaels et al., 1998; Douglas and Leeman, 2011; Douglas et al., 2001 Douglas et al., , 2008 Fundeburg et al., 2010) and TF (Key et al., 1998; Michaels et al., 1998; Fundeburg et al., 2010) are elevated in patients with vaso-occlusive disorders including sickle cell disease (SCD), human immunodeficiency virus (HIV) infection, and other conditions (Douglas and Leeman, 2011) . A number of newly identified regulatory molecules including gas6 (Hurtado and de Frutos, 2010), CD40L (Andre et al., 2002) , semaphorin 4D (Zhu et al., 2007) , semaphorin 3A (Kashiwagi et al., 2005) and ephrins/eph kinases (Prevost et al., 2002) were discovered and have a role in the mechanism of thrombus formation. SP treatment stimulates activation and aggregation of platelets and platelets contain SP immunoreactivity that is released upon activation (Jones et al., 2008) . In this study we demonstrate that SP, a member of the tachykinin family, may also contribute to thrombus formation by stimulating the expression of TF on monocytes.
SP is an important neuroimmune stimulator of innate immune functions of monocytes/macrophages (Bremer and Leeman, 2010) , released from the nucleus of the solitary tract in the brainstem and other central nervous system (CNS) sites (Bost, 2004) . In addition, it is a potent pro-inflammatory mediator which plays an important role in inflammation and HIV infection (Michaels et al., 1998) . SP mediates the biologic responses through an interaction with the NK1-R, a G-protein coupled receptor characterized by seven transmembrane domains (Lucey et al., 1994) . NK1-R is present on immune cells (Khawaja and Rogers, 1996; Ho et al., 1997) such as monocytes/macrophages (Lucey et al., 1994; Ho et al., 1997) , neutrophils (Wozniak et al., 1989) , T and B lymphocytes (Payan et al., 1984; Stanisz et al., 1987; Lai et al., 1998) , and mast cells (Shanahan et al., 1985) . There are two isoforms of NK1-R: full length NK1-R (NK1-RF) composed of 407 amino acids (aa), and a naturally occurring splice variant with a truncated C-terminus which is designated truncated NK1-R (NK1-RT) (Fong et al., 1992; Satake and Kawada, 2006; Zhang et al., 2006) , which has a 311 aa sequence with a short carboxyl terminal sequence, extending only 7 aa residues after the end of the seventh transmembrane segment (Lai et al., 2006; Tuluc et al., 2009) . The remaining aa sequence of the NK1-RT isoform is identical to that of NK1-R-F21 (Fong et al., 1992) . This interaction occurs in several cell systems and is involved in exocrine gland secretion, endocrine secretion, pain transmission, vasodilatation, connective tissue cell proliferation, and neuroimmune modulation (Bost, 2004; Satake and Kawada, 2006) . The NK1-RT probably mediates prolonged cellular responsiveness after stimulation and is resistant to homologous desensitization in comparison to the NK1-RF isoform because the missing C-terminal domain is essential for internalization, receptor desensitization and recycling (Tuluc et al., 2009 ). NK1-RA are a novel therapeutic approach to stress, mood therapy, and control of emesis (Blume et al., 2011; Douglas and Leeman, 2011) . NK1-RA Journal of Neuroimmunology 242 (2012) 1-8
